2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1184760811 M.D.
Verify on CMS →

PETER HANNOUSH, M.D.

Endocrinology, Diabetes & Metabolism Physician in HACKENSACK, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 413 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
57%
generic claims · 43% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
20.7545/100
▼ 62 pts below national avg 83.1 · [object Object]

What the federal data shows

PETER HANNOUSH, M.D. reported a CMS MIPS final score of 20.7545/100 — below the 83.1 national average — and filed 3,390 Medicare Part D claims in 2023.

20.7545/100
MIPS score · -62 vs avg
3K
Part D claims, 2023
57%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

PETER HANNOUSH, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

21 2nd percentile higher than 2% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). This entry sits in this band. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

PETER HANNOUSH, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about PETER HANNOUSH, M.D.?

Below national average

NPI registry status

Active

Issued 01/29/2007

NPI 1184760811

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

3,390 28% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

20.7545/100 62.345499999999994% pts

Below average band

vs 83.1 national avg

Specialty distribution in New Jersey

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New Jersey providers

New Jersey providers

Endocrinology, Diabetes & Metabolism Physician share within New Jersey

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within New Jersey

Medicare quality performance — MIPS

PETER HANNOUSH, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Below national average
MIPS Final Score
20.7545/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 20.7545/100 vs national avg 83.1

0%100%National avg83%20.8%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 20.7545/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PETER HANNOUSH, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 380 SUTTON AVE, HACKENSACK, NJ, 07601, with a listed phone of (201) 488-8766. NPI 1184760811 was issued on 01/29/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HANNOUSH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,390 prescription claims written by this provider, covering 413 Medicare beneficiaries and totaling roughly $1.5 million in drug spend, split 43% brand-name and 57% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 20.7545/100 for the 2023 performance year (Quality 0, Cost 69.1815), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

380 SUTTON AVE
HACKENSACK, NJ 07601

Provider Details

NPI 1184760811
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Male
NPI Issued 01/29/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

20.7545
Final Score
Avg: 83.1
0
Quality
69.1815
Cost

Reporting: Individual

Brand vs generic prescribing mix · Above average

PETER HANNOUSH, M.D. — brand share 43.0%
Specialty average (est.)

43% brand-name claims vs 57% generic, on 3,390 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,390
Total Claims
$1.5M
Total Drug Cost
413
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
8,416
Total Day Supply
250,517
Brand vs Generic
43% brand / 57% generic
Brand Drug Cost
$1.4M
Generic Drug Cost
$40K

Patient Demographics

Average Patient Age
75.5 years
Avg HCC Risk Score
1.78
Gender Split
56% female / 44% male
Age Distribution
<65: 24, 65-74: 155, 75-84: 182, 85+: 52

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What PETER HANNOUSH, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
574
Metformin Hcl
295
Farxiga
Dapagliflozin Propanediol
206
Glipizide
160
Glimepiride
120
Trulicity
Dulaglutide
116
Atorvastatin Calcium
112
Jardiance
Empagliflozin
112
Humalog Kwikpen U-100
Insulin Lispro
110
Rosuvastatin Calcium
81

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How PETER HANNOUSH, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

PETER HANNOUSH, M.D.'s 3,390 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as HANNOUSH.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is PETER HANNOUSH, M.D.'s specialty?
PETER HANNOUSH, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in HACKENSACK, New Jersey. Credentials: M.D..
How much does PETER HANNOUSH, M.D. prescribe under Medicare Part D?
In 2023, PETER HANNOUSH, M.D. wrote 3,390 Medicare Part D claims totaling $1.5M in drug costs for 413 beneficiaries.
What is PETER HANNOUSH, M.D.'s Medicare quality score?
PETER HANNOUSH, M.D. has a CMS MIPS Final Score of 20.7545/100 (Quality: 0, Cost: 69.1815). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is PETER HANNOUSH, M.D. located?
PETER HANNOUSH, M.D. is located at 380 SUTTON AVE, HACKENSACK, NJ, 07601. Phone: (201) 488-8766.
What is PETER HANNOUSH, M.D.'s NPI number?
PETER HANNOUSH, M.D.'s National Provider Identifier (NPI) is 1184760811, issued on 01/29/2007.
Does PETER HANNOUSH, M.D. prescribe more brand-name or generic drugs?
PETER HANNOUSH, M.D.'s prescribing is 43% brand-name and 57% generic drugs by claim count, with $1.4M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does PETER HANNOUSH, M.D. prescribe most often?
Based on 2023 Medicare Part D data, PETER HANNOUSH, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Farxiga. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PETER HANNOUSH, M.D. accept Medicare?
PETER HANNOUSH, M.D. appears in CMS Medicare data with 3,390 Part D claims and 413 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PETER HANNOUSH, M.D.'s credentials?
PETER HANNOUSH, M.D.'s NPI is 1184760811 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology